Wu-Mei-wan protects pancreatic β cells by inhibiting NLRP3 Inflammasome activation in diabetic mice

• Main Authors: Xueping Yang (Author), Fuer Lu (Author), Lingli Li (Author), Jingbin Li (Author), Jinlong Luo (Author), Siyi Zhang (Author), Xinqiao Liu (Author), Guang Chen (Author)
• Format: Book
• Published: BMC, 2019-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Wu-Mei-Wan (WMW) is a traditional Chinese herbal formulation that is clinically prescribed to treat diabetes mellitus in China. WMW has been shown to alleviate damage in pancreatic β cells, but the underlying mechanism remains unclear. This study aims to explore how WMW plays a p...